Synlogic, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SYBX research report →
About the company
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases.
- CEO
- Mary Beth Dooley
- IPO
- 2015
- Employees
- 1
- HQ
- Winchester, MA, US
Price Chart
- Market Cap
- $8.20M
- P/E
- -13.25
- P/S
- 0.00
- P/B
- 0.69
- EV/EBITDA
- 1.61
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -5.42%
- ROIC
- -36.84%
- Revenue
- $0 · -100.00%
- Net Income
- $-1,005,000 · 95.70%
- EPS
- $-0.08 · 95.83%
- Op Income
- $-4,008,000
- FCF YoY
- 86.24%
- 52W High
- $1.96
- 52W Low
- $0.54
- 50D MA
- $0.67
- 200D MA
- $1.01
- Beta
- 0.54
- Avg Volume
- 14.70K
Get TickerSpark's AI analysis on SYBX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 29, 25 | Dooley Mary Beth | sell | 157 |
| Apr 26, 25 | Shea Richard P | other | 15,000 |
| Apr 26, 25 | Flynn James P | other | 15,000 |
| Apr 2, 25 | Dooley Mary Beth | sell | 144 |
| Feb 3, 25 | Dooley Mary Beth | sell | 2,107 |
| Oct 29, 24 | Dooley Mary Beth | sell | 79 |
| Apr 2, 24 | Dooley Mary Beth | sell | 188 |
| Apr 2, 24 | Awad Antoine | sell | 372 |
| Mar 18, 24 | Dooley Mary Beth | other | 0 |
| Mar 18, 24 | Dooley Mary Beth | other | 3,612 |
Our SYBX coverage
Recent articles, reports, and earnings notes.
No research on SYBX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SYBX report →Similar companies
Peers in the same neighborhood.